
NYSE:LDOS
This summary was created by AI, based on 8 opinions in the last 12 months.
Leidos (LDOS) has recently shown strong earnings performance, beating revenue estimates consistently over the last two years and showcasing significant organic growth. The company reported impressive earnings of $3.05 per share, exceeding expectations, and generated record revenues of over $4.5 billion. However, concerns linger regarding potential pressures from the government on consulting costs as well as the substantial healthcare contract with veteran hospitals that may impact future performance. While some experts express caution and recommend adjusting stop-loss levels, others continue to express confidence in the management and growth trajectory of the company, highlighting its resilience in the defense sector and ongoing positive execution of strategic plans. Overall, sentiment is mixed, with some experts advocating for a cautious approach amidst a challenging market environment.
LDOS is a $20B market cap company providing scientific, engineering and technical services. The stock is up 36% YTD and 90% over one year. It trades at 16X earnings, with a 1.03% dividend. Historical growth has been very solid, and it generates good cash flow. The last quarter was excellent and EPS beat estimates by 35%. Estimates have also been moving up. There is a lot to like here for sure. Our main concern would be debt, at about 4X cash flow. But based on its growth and execution we would not see this as particularly problematic.
Unlock Premium - Try 5i Free
Leidos is a American stock, trading under the symbol LDOS (previously LDOS-N on Stockchase) on the New York Stock Exchange (LDOS). It is usually referred to as NYSE:LDOS or LDOS
In the last year, 8 stock analysts issued a Buy, Sell, or Hold rating on LDOS (previously LDOS-N on Stockchase). 7 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Leidos.
Leidos was recommended as a Top Pick by Stephen Weiss, Founder, Short Hills Capital Partners on 2024-05-01. Read the latest stock experts ratings for Leidos.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Leidos.
Leidos is followed by 24 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-24, Leidos (LDOS) stock closed at a price of $104.71.
He sold it. It will stay at current levels. The big issue is the government is after all these consulting companies to lower their costs. Also, they have a big healthcare contract with the veteran hospitals, which is an overhang. Management is good, though.